Quick Answer
Riboflavin Fatigue Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: The etiology of fatigue in IBD is multifactorial and may be associated with inflammation, anemia, nutrient deficiencies, medications, and microbiota.
Key Takeaways
- 01The etiology of fatigue in IBD is multifactorial and may be associated with inflammation, anemia, nutrient deficiencies, medications, and microbiota. [MORAIS Tayane (2026)]
- 02Fatigue in patients with IBD is associated with decreased physical functioning, mood disturbances, and low productivity, presenting symptoms of physical and mental exhaustion. [MORAIS Tayane (2026)]
- 03The guiding question for this study was: what is the current scientific evidence, over the last seven years, on the pharmacological treatment of fatigue in patients with IBD? [MORAIS Tayane (2026)]
- 04, , Inflammatory bowel disease (IBD) is a chronic inflammatory condition that results from the interaction between genetic and environmental factors that influence immune responses and one’s quality of life. [MORAIS Tayane (2026)]
The current Migaku evidence database contains 1 reusable source document for Riboflavin Fatigue Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation.
- The etiology of fatigue in IBD is multifactorial and may be associated with inflammation, anemia, nutrient deficiencies, medications, and microbiota. [MORAIS Tayane (2026); evidence level 4]
- Fatigue in patients with IBD is associated with decreased physical functioning, mood disturbances, and low productivity, presenting symptoms of physical and mental exhaustion. [MORAIS Tayane (2026); evidence level 4]
- The guiding question for this study was: what is the current scientific evidence, over the last seven years, on the pharmacological treatment of fatigue in patients with IBD? [MORAIS Tayane (2026); evidence level 4]
- , , Inflammatory bowel disease (IBD) is a chronic inflammatory condition that results from the interaction between genetic and environmental factors that influence immune responses and one’s quality of life. [MORAIS Tayane (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources